慢性肝病与血小板减少：临床处理观念的转变

doi:10.3969/j.issn.1672-5069.2019.04.001

Abstract

Tang Chengwei. Chronic liver disease and thrombocytopenia：Changes in clinical management concept[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 457-458.

[1] Humbrecht C,Kientz D,Gachet C.Platelet transfusion: Current challenges. Transfus Clin Biol. 2018,25(3):151-164.
[2] 文良志,熊吉,孙文静,等. 肝硬化与骨髓造血.实用肝脏病杂志,2017,20(4):391-393.
[3] Saab S,Brown RS Jr. Management of Thrombocytopenia in Patients with Chronic Liver Disease. Dig Dis Sci.2019 Apr 22. doi:10.1007/s10620-019-05615-5.[Epub ahead of print]
[4] Mitchell O,Feldman DM,Diakow M,et al.The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016,8:39-50.
[5] 中华医学会肝病学分会、消化病学分会、内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 实用肝脏病杂志,2016,19(5):I-XVI.
[6] 陈世耀,黄晓铨,曾晓清.门静脉高压症的检查选择与病因诊断.实用肝脏病杂志,2018,21(3):321-324.
[7] 姚小健,黄红霞,陈勇. 乙型肝炎肝硬化患者血清血小板衍生生长因子和叶酸水平变化. 实用肝脏病杂志,2018,21(1):76-79.
[8] 汤诗杭,高锦航,唐承薇. 环氧合酶在肝硬化门静脉高压中的作用和机制. 中华消化杂志,2017,37(10):717-720.
[9] Luo X,Nie L,Wang Z,et al.Transjugular endovascular recanalization of splenic vein in patients with regional portal hypertension complicated by gastrointestinal bleeding. Cardiovasc Intervent Radiol. 2014,37(1):108-13.
[10] Tang Y,Zheng S,Yang J,et al.Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients. Medicine(Baltimore). 2017,96(49):e8678.
[11] Gao JH,Wen SL,Tong H,et al.Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats. Am [J] Physiol Gastrointest Liver Physiol. 2016,310(11):G962-72.
[12] Gao JH,Wen SL,Feng S,et al.Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. Angiogenesis. 2016,19(4):501-11.
[13] Wen SL,Gao JH,Yang WJ,et al.Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes. [J] Gastroenterol Hepatol. 2014,29(11):1932-42.
[14] Gao JH,Wen SL,Yang WJ,et al.Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis. PLoS One. 2013,8(7):e69309.

[1]	Ding Wenjin, Fan Jiangao.. Management of complications associated with cholestatic liver disease [J]. Journal of Practical Hepatology, 2019, 22(6): 938-940.
[2]	. [J]. Journal of Practical Hepatology, 2019, 22(5): 624-635.
[3]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[4]	Han Meiling, Chen Ping. Antiviral therapy in patients with liver cirrhosis and thrombocytopenia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 466-469.
[5]	Su Shuting, Zhong Yan, Mi Yuqiang.. Management of patients with non-alcoholic fatty liver disease [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 293-296.
[6]	Ding Yang, Dou Xiaoguang.. How to achieve zero mother-to-child transmission of hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 4-5.
[7]	Zhu Yage, Lei Chunmei, Guo Dandan, et al.. Followed-up and management of pregnant women with chronic hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 45-48.
[8]	Yang Ruixu, Fan Jiangao. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 496-501.
[9]	Yu Aidong, Wang Chuanjie, Li Jianfang. Application of group management by WeChat in improving compliance of patients with chronic hepatitis B receiving nucleos(t)des [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 621-622.
[10]	Guo Wei, Zhao Jinyu, Qi Chunyan. Pain management on the quality of life in patients with advanced primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 641-642.
[11]	Zhang Ming, Zhuge Yuzheng, Zou Xiaoping. Application of interventional techniques in patients with unknown etiologic portal hypertension [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 329-331.
[12]	Wang Yanxin, Yu Hongwei, Zhu Yueke. Nutritional assessment and treatment in patients with chronic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 317-320.
[13]	Sun Lin, Wang Dan, Wu Donghan. Impact of intrahepatic cholestasis of pregnancyon the outcomes of infants [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 133-134.
[14]	Gu Chuan，Xu Xiaoyuan.. Management of upper gastrointestinal hemorrhage in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 527-528.
[15]	Chen Liuying, Lu Lungen.. Evaluation of chronic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 4-6.

Chronic liver disease and thrombocytopenia：Changes in clinical management concept

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments